Farther Finance Advisors’s ADC Therapeutics ADCT Stock Holding History

Farther Finance Advisors’s Portfolio ADCT Stock Details ADCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$303	Buy	248 +51	+26%	+$60	﹤0.01%	5821
2026 Q2	$211	Buy	+197	New	+$575	﹤0.01%	5707
2026 Q1	–	Sell	-57	Closed	-$201	–	5755
2025 Q4	$201	Buy	+57	New	+$231	﹤0.01%	5209

Other funds holding ADCT

DIM

DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's ADCT Position: Q3 2026 in Review

Farther Finance Advisors increased its ADC Therapeutics (ADCT) stake by 26% in Q3 2026, buying an estimated $60 and bringing the position to 248 shares worth $303. The position accounts for ﹤0.01% of the portfolio, ranked #5821.

Farther Finance Advisors first reported a position in ADCT in Q4 2025 and has held it in 3 quarters since. 4 funds tracked by Wall St. Rank hold ADCT as of Q3 2026.

Farther Finance Advisors held 248 shares of ADC Therapeutics worth $303 as of Q3 2026.
Farther Finance Advisors bought 51 ADC Therapeutics shares in Q3 2026, an estimated $60.
ADC Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5821 holding.
Farther Finance Advisors first reported a position in ADC Therapeutics in Q4 2025 and has held it in 3 quarters since.
4 funds tracked by Wall St. Rank held ADC Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.